An arsenic oxide in which arsenic and oxygen atoms are present in the ratio 2:3.
Chemical ID:
MESH:C006632
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[Resveratrol co-treated with Arsenic Trioxide] results in increased expression of NQO1 protein, Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein], allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein], MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein], NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein], Tretinoin inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]
[Arsenic Trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NQO1 mRNA, Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 mRNA], Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NQO1 mRNA], Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NQO1 protein], Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA], Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]], Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA], Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein], NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]
